PGILX
Price
$37.68
Change
+$0.29 (+0.78%)
Updated
Jul 3 closing price
Net Assets
690.67M
RGAHX
Price
$81.72
Change
+$0.80 (+0.99%)
Updated
Jul 3 closing price
Net Assets
322.86B
Interact to see
Advertisement

PGILX vs RGAHX

Header iconPGILX vs RGAHX Comparison
Open Charts PGILX vs RGAHXBanner chart's image
Putnam Focused Equity Y
Price$37.68
Change+$0.29 (+0.78%)
VolumeN/A
Net Assets690.67M
American Funds Growth Fund of Amer R5E
Price$81.72
Change+$0.80 (+0.99%)
VolumeN/A
Net Assets322.86B
PGILX vs RGAHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PGILX vs. RGAHX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGILX is a Buy and RGAHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 323B vs. PGILX (691M). RGAHX pays higher dividends than PGILX: RGAHX (0.47) vs PGILX (0.30). PGILX was incepted earlier than RGAHX: PGILX (17 years) vs RGAHX (10 years). PGILX (0.86) is less costly to investors than RGAHX (0.44). PGILX is a more actively managed with annual turnover of: 30.00 vs. RGAHX (25.00). PGILX has a lower initial minimum investment than RGAHX: PGILX (0) vs RGAHX (250). RGAHX annual gain was more profitable for investors over the last year : 10.98 vs. PGILX (5.69). PGILX return over 5 years is better than : 74.88 vs. RGAHX (50.13).
PGILXRGAHXPGILX / RGAHX
Total Expense Ratio0.860.44195%
Annual Report Gross Expense Ratio0.860.44195%
Fund Existence17 years10 years-
Gain YTD8.05911.27571%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets691M323B0%
Annual Yield % from dividends0.300.4763%
Returns for 1 year5.6910.9852%
Returns for 3 years52.7960.1488%
Returns for 5 years74.8850.13149%
Returns for 10 years134.34N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRVI5.950.25
+4.39%
Trevi Therapeutics
LYEL9.690.26
+2.76%
Lyell Immunopharma Inc
APTV72.560.37
+0.51%
Aptiv PLC
UA6.87N/A
N/A
Under Armour
PAVS0.90-0.02
-1.85%
Paranovus Entertainment Technology Ltd